Patent details

300086 Product Name: Imatinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zuuradditiezout, in het bijzonder het mesilaat.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300086
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP0564409
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300086
Procedural language:
Dutch
First Applicant Residence Country:

Paediatric Extension

SPC Extension Filing Date:
03/12/2013
SPC Extension Agent/Owner Name:
ir. M.F.J.M. Ketelaars c.s. , Novartis AG
SPC Extension Status:
Extension Granted
SPC Extension Grant Date:
19/03/2014
SPC Extension Request Refusal Date:
SPC Extension Revocation Date:

Marketing Authorization

1

Marketing Authorization Number:
IKS 55807
Marketing Authorization Type:
EEA
Marketing Authorization Date:
21/06/2001
Marketing Authorization Country:
Switzerland (CH)

2

Marketing Authorization Number:
EU/1/01/198/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/11/2001
Marketing Authorization Country:
European Union (EU)

3

Marketing Authorization Number:
EU/1/01/198/002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/11/2001
Marketing Authorization Country:
European Union (EU)

4

Marketing Authorization Number:
EU/1/01/198/003
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/11/2001
Marketing Authorization Country:
European Union (EU)

5

Marketing Authorization Number:
EU/1/01/198/004
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/11/2001
Marketing Authorization Country:
European Union (EU)

6

Marketing Authorization Number:
EU/1/01/198/005
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/11/2001
Marketing Authorization Country:
European Union (EU)

7

Marketing Authorization Number:
EU/1/01/198/006
Marketing Authorization Type:
EEA
Marketing Authorization Date:
07/11/2001
Marketing Authorization Country:
European Union (EU)

8

Marketing Authorization Number:
EU/1/01/198/001
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
07/11/2001
Marketing Authorization Country:
European Union (EU)

9

Marketing Authorization Number:
EU/1/01/198/002
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
07/11/2001
Marketing Authorization Country:
European Union (EU)

10

Marketing Authorization Number:
EU/1/01/198/003
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
07/11/2001
Marketing Authorization Country:
European Union (EU)

11

Marketing Authorization Number:
EU/1/01/198/004
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
07/11/2001
Marketing Authorization Country:
European Union (EU)

12

Marketing Authorization Number:
EU/1/01/198/005
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
07/11/2001
Marketing Authorization Country:
European Union (EU)

13

Marketing Authorization Number:
EU/1/01/198/006
Marketing Authorization Type:
National/EU
Marketing Authorization Date:
07/11/2001
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
01/03/2002
First Marketing Authorization date:
21/06/2001
Grant date:
15/04/2002
Activation date:
25/03/2013
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
01/03/2002
SPC/SPC Extension Expiration Date:
20/12/2016
Lapsed By Expiration Date:
21/12/2016
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
24/02/2016
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Historical Applicant/holder

From:
24/02/2016
To:
24/02/2016

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
01/03/2002
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Licensee

1

Name:
Novartis Pharma AG
From:
24/02/2016
Address:
Lichtstrasse 35, CH-4002, Basel, Switzerland (CH)
To:

2

Name:
Novartis Pharma B.V.
From:
24/02/2016
Address:
Raapopseweg 1, 6824 DP, Arnhem, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
51/16
Publication date:
21/12/2016
Description:
Contains data concerning lapse or annulment

2

Bulletin Heading:
MED
Journal edition number:
23/16
Publication date:
10/06/2016
Description:
Contains data concerning other communications

3

Bulletin Heading:
MED
Journal edition number:
23/16
Publication date:
10/06/2016
Description:
Contains data concerning other communications

4

Bulletin Heading:
MED
Journal edition number:
2014/13
Publication date:
26/03/2014
Description:
Contains data concerning other communications

5

Bulletin Heading:
MED
Journal edition number:
2013/50
Publication date:
11/12/2013
Description:
Contains data concerning other communications

6

Bulletin Heading:
SPC
Journal edition number:
2013/15
Publication date:
10/04/2013
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

7

Bulletin Heading:
SPC
Journal edition number:
2002/06
Publication date:
03/06/2002
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

8

Bulletin Heading:
SPC
Journal edition number:
2002/05
Publication date:
01/05/2002
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC201601064A
Date Registered:
24/02/2016
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
RC201601064B
Date Registered:
24/02/2016
License Effective Date:
24/02/2016
License Expiration Date:
Scope of License:
Not Exclusive
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Netherlands (NL)
Updated License Number:
Terminated License Number:

Added Licensee(s)

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, CH-4002, Basel, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
RC201601065A
Date Registered:
24/02/2016
License Effective Date:
24/02/2016
License Expiration Date:
Scope of License:
Not Exclusive
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Indiening niet exclusieve licentie op 24 februari 2016 door NLO te Den Haag. Licentiegever is Novartis AG te Basel in Zwitserland. Licentiehouder is Novartis Pharma B.V. te Arnhem. Zie verder de akte.
Deed Status:
Country Code:
Netherlands (NL)
Updated License Number:
Terminated License Number:

Added Licensee(s)

Name:
Novartis Pharma B.V.
Address:
Raapopseweg 1, 6824 DP, Arnhem, Netherlands (NL)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Other

Note:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
24/03/2016
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
2200 Euro
Payer:
Arnold & Siedsma BV
Filing date Document type Document Description Number of pages
01/06/2016 Outgoing Correspondence Outgoing Letter 1 /6/8/0/0/0/0400300086/docs/300086_24_59866l118.pdf
01/06/2016 Outgoing Correspondence Outgoing Letter 1 /6/8/0/0/0/0400300086/docs/300086_31_59698l118.pdf
24/02/2016 Incoming Correspondence Paper Accompanying letter incoming document 2 /6/8/0/0/0/0400300086/docs/300086_0_incomingcorrespondencepaper20160602125438614.pdf
24/02/2016 Incoming Correspondence Paper Accompanying letter incoming document 1 /6/8/0/0/0/0400300086/docs/300086_1_incomingcorrespondencepaper20160602011551677.pdf
24/02/2016 Request for Change Subsequently filed deed 4 /6/8/0/0/0/0400300086/docs/300086_22_rfc20160602011551759.pdf
24/02/2016 Request for Change Subsequently filed deed 3 /6/8/0/0/0/0400300086/docs/300086_29_rfc20160602125438666.pdf
18/03/2014 SPC Documents Decision SPC 1 /6/8/0/0/0/0400300086/docs/300086_2_supplprotectioncertificate20170103041859588.pdf
18/03/2014 SPC Documents Certificate SPC 1 /6/8/0/0/0/0400300086/docs/300086_30_supplprotectioncertificate20170103041259807.pdf
05/12/2013 Outgoing Correspondence Outgoing Letter 1 /6/8/0/0/0/0400300086/docs/300086_13_outgoingcorrespondence20131205.pdf
03/12/2013 General 35 /6/8/0/0/0/0400300086/docs/300086_4_spc-documents20131203.pdf
03/12/2013 Incoming Correspondence Paper Other 21 /6/8/0/0/0/0400300086/docs/300086_17_incomingcorrespondencepaper20131203.pdf
03/12/2013 Incoming Correspondence Paper Accompanying letter incoming document 1 /6/8/0/0/0/0400300086/docs/300086_20_incomingcorrespondencepaper20131203.pdf
03/12/2013 Incoming Correspondence Paper Other 2 /6/8/0/0/0/0400300086/docs/300086_21_incomingcorrespondencepaper20131203.pdf
03/12/2013 Incoming Correspondence Paper Other 5 /6/8/0/0/0/0400300086/docs/300086_32_incomingcorrespondencepaper20131203.pdf
03/12/2013 Incoming Correspondence Paper Other 5 /6/8/0/0/0/0400300086/docs/300086_34_incomingcorrespondencepaper20131203.pdf
05/01/2006 General 1 /6/8/0/0/0/0400300086/docs/300086_10_spc-documents20060105.pdf
05/01/2006 General 5 /6/8/0/0/0/0400300086/docs/300086_12_spc-documents20060105.pdf
05/01/2006 General 1 /6/8/0/0/0/0400300086/docs/300086_16_spc-documents20060105.pdf
15/04/2002 Outgoing Correspondence Outgoing Letter 1 /6/8/0/0/0/0400300086/docs/300086_14_outgoingcorrespondence20020415.pdf
15/04/2002 Outgoing Correspondence Outgoing Letter 1 /6/8/0/0/0/0400300086/docs/300086_15_outgoingcorrespondence20020415.pdf
15/04/2002 Outgoing Correspondence Outgoing Letter 4 /6/8/0/0/0/0400300086/docs/300086_18_outgoingcorrespondence20020415.pdf
15/04/2002 Outgoing Correspondence Outgoing Letter 1 /6/8/0/0/0/0400300086/docs/300086_19_outgoingcorrespondence20020415.pdf
15/04/2002 Outgoing Correspondence Outgoing Letter 1 /6/8/0/0/0/0400300086/docs/300086_23_outgoingcorrespondence20020415.pdf
15/04/2002 Outgoing Correspondence Outgoing Letter 1 /6/8/0/0/0/0400300086/docs/300086_25_outgoingcorrespondence20020415.pdf
15/04/2002 Outgoing Correspondence Outgoing Letter 1 /6/8/0/0/0/0400300086/docs/300086_28_outgoingcorrespondence20020415.pdf
27/03/2002 General 2 /6/8/0/0/0/0400300086/docs/300086_9_spc-documents20020327.pdf
19/03/2002 General 1 /6/8/0/0/0/0400300086/docs/300086_26_spc-documents20020319.pdf
19/03/2002 General 1 /6/8/0/0/0/0400300086/docs/300086_27_spc-documents20020319.pdf
15/03/2002 General 1 /6/8/0/0/0/0400300086/docs/300086_5_spc-documents20020315.pdf
01/03/2002 General 1 /6/8/0/0/0/0400300086/docs/300086_3_spc-documents20020301.pdf
01/03/2002 General 1 /6/8/0/0/0/0400300086/docs/300086_6_spc-documents20020301.pdf
01/03/2002 Incoming Correspondence Paper Accompanying letter incoming document 1 /6/8/0/0/0/0400300086/docs/300086_7_incomingcorrespondencepaper20020301.pdf
01/03/2002 General 27 /6/8/0/0/0/0400300086/docs/300086_8_spc-documents20020301.pdf
01/03/2002 General 1 /6/8/0/0/0/0400300086/docs/300086_11_spc-documents20020301.pdf
01/03/2002 Application Form First filed application form 2 /6/8/0/0/0/0400300086/docs/300086_33_applicationform20020301.pdf
01/03/2002 General 4 /6/8/0/0/0/0400300086/docs/300086_35_spc-documents20020301.pdf